» Articles » PMID: 24781435

The Multiple Mechanistic Faces of a Pure Volume Overload: Implications for Therapy

Overview
Journal Am J Med Sci
Publisher Elsevier
Specialty General Medicine
Date 2014 May 1
PMID 24781435
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

: Mitral regurgitation and other conditions marked by a pure isolated volume overload (VO) of the heart result in a progressive form of eccentric left ventricular remodeling and dysfunction. As opposed to the more extensively studied pressure overload, there are no approved medical therapies because an understanding of the underlying pathological mechanisms at work in VO is lacking. Over the past 20 years, our laboratory has identified multiple key biological functions involved in the pathological remodeling in VO. Specifically, we have noted perturbed matrix homeostasis, detrimental adrenergic signaling, increased intracellular reactive oxygen species and an intense inflammatory response that implicates mast cells and their product chymase, which seems to cause extensive remodeling both inside and outside the cardiomyocyte. How these multiple pathways intersect over the course of VO and their response to various single and combined interventions are now the subject of intense investigation.

Citing Articles

Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody.

Cohen L, Sagi I, Bigelman E, Solomonov I, Aloshin A, Ben-Shoshan J PLoS One. 2020; 15(4):e0231202.

PMID: 32271823 PMC: 7145114. DOI: 10.1371/journal.pone.0231202.


Cardiac Tissue Chips (CTCs) for Modeling Cardiovascular Disease.

Rogers A, Miller J, Kannappan R, Sethu P IEEE Trans Biomed Eng. 2019; 66(12):3436-3443.

PMID: 30892197 PMC: 6894902. DOI: 10.1109/TBME.2019.2905763.


Transcriptional Changes Associated with Long-Term Left Ventricle Volume Overload in Rats: Impact on Enzymes Related to Myocardial Energy Metabolism.

Roussel E, Drolet M, Walsh-Wilkinson E, Dhahri W, Lachance D, Gascon S Biomed Res Int. 2015; 2015:949624.

PMID: 26583150 PMC: 4637065. DOI: 10.1155/2015/949624.


Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload.

Yancey D, Guichard J, Ahmed M, Zhou L, Murphy M, Johnson M Am J Physiol Heart Circ Physiol. 2015; 308(6):H651-63.

PMID: 25599572 PMC: 4360051. DOI: 10.1152/ajpheart.00638.2014.

References
1.
Pat B, Killingsworth C, Denney T, Zheng J, Powell P, Tillson M . Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation. Am J Physiol Heart Circ Physiol. 2008; 295(6):H2321-7. PMC: 2614546. DOI: 10.1152/ajpheart.00746.2008. View

2.
Urata H, Kinoshita A, Misono K, BUMPUS F, Husain A . Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990; 265(36):22348-57. View

3.
Tsutsui H, Spinale F, Nagatsu M, Schmid P, Ishihara K, DeFreyte G . Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 1994; 93(6):2639-48. PMC: 294505. DOI: 10.1172/JCI117277. View

4.
Newton G, Azevedo E, Parker J . Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study. Circulation. 1999; 99(18):2402-7. DOI: 10.1161/01.cir.99.18.2402. View

5.
Urata H, Healy B, Stewart R, BUMPUS F, Husain A . Angiotensin II-forming pathways in normal and failing human hearts. Circ Res. 1990; 66(4):883-90. DOI: 10.1161/01.res.66.4.883. View